Holder Weiss Asset Management LP Has Upped Celgene (CELG) Stake; Tygh Capital Management Position in Dycom Industries (DY) Increased by $1.97 Million

Celgene Corporation (NASDAQ:CELG) Logo

Andrew Weiss increased its stake in Celgene Corp (CELG) by 196.53% based on its latest 2017Q4 regulatory filing with the SEC. Weiss Asset Management Lp bought 7,537 shares as the company’s stock declined 19.30% with the market. The hedge fund run by Andrew Weiss held 11,372 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $1.19M, up from 3,835 at the end of the previous reported quarter. Weiss Asset Management Lp who had been investing in Celgene Corp for a number of months, seems to be bullish on the $68.58B market cap company. The stock decreased 0.98% or $0.9 during the last trading session, reaching $91.18. About 4.21 million shares traded. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since April 30, 2017 and is downtrending. It has underperformed by 42.83% the S&P500.

Tygh Capital Management Inc increased its stake in Dycom Industries Inc (DY) by 14.14% based on its latest 2017Q4 regulatory filing with the SEC. Tygh Capital Management Inc bought 17,725 shares as the company’s stock declined 9.19% with the market. The institutional investor held 143,072 shares of the basic industries company at the end of 2017Q4, valued at $15.94M, up from 125,347 at the end of the previous reported quarter. Tygh Capital Management Inc who had been investing in Dycom Industries Inc for a number of months, seems to be bullish on the $3.33B market cap company. The stock decreased 0.84% or $0.9 during the last trading session, reaching $106.65. About 276,636 shares traded. Dycom Industries, Inc. (NYSE:DY) has risen 13.44% since April 30, 2017 and is uptrending. It has outperformed by 1.89% the S&P500.

Weiss Asset Management Lp, which manages about $1.80B and $1.15 billion US Long portfolio, decreased its stake in National Energy Services Reu by 847,281 shares to 519,302 shares, valued at $5.17M in 2017Q4, according to the filing. It also reduced its holding in Priceline Grp Inc (NASDAQ:PCLN) by 564 shares in the quarter, leaving it with 836 shares, and cut its stake in Ani Pharmaceuticals Inc (NASDAQ:ANIP).

Since February 8, 2018, it had 1 buying transaction, and 3 sales for $3.58 million activity. Another trade for 13,370 shares valued at $1.26M was made by MARIO ERNEST on Friday, February 23. $851,093 worth of Celgene Corporation (NASDAQ:CELG) was sold by LOUGHLIN JAMES J on Monday, March 12. Another trade for 18,500 shares valued at $1.77M was made by KAPLAN GILLA on Thursday, February 15.

Investors sentiment decreased to 0.83 in 2017 Q4. Its down 0.34, from 1.17 in 2017Q3. It fall, as 156 investors sold CELG shares while 478 reduced holdings. 118 funds opened positions while 411 raised stakes. 561.38 million shares or 7.06% less from 603.99 million shares in 2017Q3 were reported. Stock Yards Bancshares & Tru reported 147,819 shares stake. Invesco Ltd owns 12.58M shares or 0.47% of their US portfolio. Hikari Tsushin Incorporated holds 33,782 shares or 0.92% of its portfolio. Hm Payson And accumulated 109,574 shares. First National Bank, a Illinois-based fund reported 24,533 shares. Allen Invest Lc owns 4,154 shares. Gsa Capital Limited Liability Partnership owns 34,830 shares. 37,994 were accumulated by Majedie Asset Mgmt Ltd. Selway Asset has 24,025 shares for 1.47% of their portfolio. Fdx Advsr Incorporated reported 23,699 shares. Bedrijfstakpensioenfonds Voor De Media Pno owns 115,000 shares. San Francisco Sentry Invest (Ca) holds 12,478 shares. Voya Inv Mngmt Limited Liability holds 2.51 million shares. Pinnacle Wealth Management Advisory Grp Limited Liability Com owns 2,150 shares for 0.12% of their portfolio. Shaker Investments Limited Liability Company Oh invested in 0.76% or 11,003 shares.

Among 34 analysts covering Celgene Corporation (NASDAQ:CELG), 19 have Buy rating, 1 Sell and 14 Hold. Therefore 56% are positive. Celgene Corporation had 142 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Cantor Fitzgerald on Tuesday, September 26 with “Buy”. Morgan Stanley maintained the shares of CELG in report on Friday, April 13 with “Equal-Weight” rating. The stock of Celgene Corporation (NASDAQ:CELG) has “Buy” rating given on Tuesday, September 19 by Robert W. Baird. The stock of Celgene Corporation (NASDAQ:CELG) has “Buy” rating given on Monday, July 10 by Jefferies. The firm has “Buy” rating given on Wednesday, December 13 by Leerink Swann. The stock of Celgene Corporation (NASDAQ:CELG) earned “Buy” rating by Cantor Fitzgerald on Monday, August 28. The rating was maintained by Mizuho with “Buy” on Wednesday, July 26. On Wednesday, March 9 the stock rating was maintained by JMP Securities with “Market Outperform”. The firm earned “Neutral” rating on Wednesday, June 1 by BTIG Research. The stock of Celgene Corporation (NASDAQ:CELG) earned “Hold” rating by Standpoint Research on Wednesday, November 9.

Among 10 analysts covering Dycom (NYSE:DY), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. Dycom had 36 analyst reports since August 27, 2015 according to SRatingsIntel. The company was maintained on Tuesday, February 13 by Canaccord Genuity. The stock has “Buy” rating by Stifel Nicolaus on Sunday, December 10. The stock of Dycom Industries, Inc. (NYSE:DY) has “Buy” rating given on Tuesday, September 26 by Deutsche Bank. Stifel Nicolaus maintained the shares of DY in report on Thursday, May 25 with “Buy” rating. The rating was maintained by Canaccord Genuity with “Buy” on Wednesday, August 30. Stifel Nicolaus maintained the shares of DY in report on Tuesday, November 28 with “Buy” rating. The company was maintained on Thursday, August 27 by FBR Capital. As per Monday, November 9, the company rating was downgraded by DA Davidson. The firm has “Buy” rating given on Monday, June 19 by FBR Capital. The rating was maintained by FBR Capital on Wednesday, February 28 with “Buy”.

Investors sentiment increased to 1.01 in 2017 Q4. Its up 0.01, from 1 in 2017Q3. It is positive, as 34 investors sold DY shares while 109 reduced holdings. 55 funds opened positions while 89 raised stakes. 29.64 million shares or 4.71% less from 31.11 million shares in 2017Q3 were reported. Moreover, Hbk Sorce Advisory Limited Liability Corporation has 0.03% invested in Dycom Industries, Inc. (NYSE:DY). Price T Rowe Associate Inc Md holds 0% or 18,409 shares. Laurion Cap Mgmt Ltd Partnership has 0% invested in Dycom Industries, Inc. (NYSE:DY) for 5,101 shares. Ameriprise Fin has 122,677 shares for 0.01% of their portfolio. Ironwood Limited Liability Company invested 0.71% in Dycom Industries, Inc. (NYSE:DY). Guggenheim Ltd invested in 0.04% or 158,055 shares. Truenorth Incorporated holds 2,367 shares. Bank & Trust Of America De holds 0.01% of its portfolio in Dycom Industries, Inc. (NYSE:DY) for 362,431 shares. Point72 Asia (Hong Kong) Ltd holds 269 shares or 0.02% of its portfolio. University Of Texas Invest Managment has 20 shares. Rmb Cap Management Ltd Liability Com accumulated 44,445 shares. Regions Finance Corporation accumulated 7,027 shares or 0.01% of the stock. 247,611 were reported by Cortina Asset Management Ltd. Gemmer Asset Mngmt Ltd Llc invested 0.01% of its portfolio in Dycom Industries, Inc. (NYSE:DY). 325 are owned by C M Bidwell & Assoc.

Since March 7, 2018, it had 0 insider buys, and 1 insider sale for $284,044 activity.

Celgene Corporation (NASDAQ:CELG) Institutional Positions Chart